Log In
Print
BCIQ
Print
Print this Print this
 

PORxin, topsalysin (PRX302) (formerly PSA-PAH1)

  Manage Alerts
Collapse Summary General Information
Company Sophiris Bio Inc.
DescriptionRecombinant proaerolysin protein activated by prostate-specific antigen (KLK3; PSA)
Molecular Target Glycophosphatidylinositol
Mechanism of Action 
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$75.0M

0

$72.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today